Production (Stage)
10x Genomics, Inc.
TXG
$8.17
-$0.37-4.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.14% | 8.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.14% | 8.81% | |||
| Cost of Revenue | -8.56% | 19.45% | |||
| Gross Profit | -4.97% | 4.29% | |||
| SG&A Expenses | -4.37% | 14.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.33% | 11.25% | |||
| Operating Income | 2.63% | -20.14% | |||
| Income Before Tax | 30.74% | -40.48% | |||
| Income Tax Expenses | 31.48% | -50.72% | |||
| Earnings from Continuing Operations | 29.92% | -37.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.92% | -37.13% | |||
| EBIT | 2.63% | -20.14% | |||
| EBITDA | 1.42% | -26.35% | |||
| EPS Basic | 30.51% | -36.17% | |||
| Normalized Basic EPS | 12.46% | -39.48% | |||
| EPS Diluted | 30.51% | -36.17% | |||
| Normalized Diluted EPS | 12.46% | -39.48% | |||
| Average Basic Shares Outstanding | 0.83% | 0.72% | |||
| Average Diluted Shares Outstanding | 0.83% | 0.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||